Prothrombin Complex Concentrate (PCC) Drug - Global Top Players Market Share and Ranking 2025- YH Research

Home > Reports >Pharma & Healthcare > Prothrombin Complex Concentrate (PCC) Drug - Global Top Players Market Share and Ranking 2025

Prothrombin Complex Concentrate (PCC) Drug - Global Top Players Market Share and Ranking 2025

Publication Date: 2025-11-13
Report Id: 2765164
Industry: Pharma & Healthcare
Report Page: 113
Chart: 116

PDF Download

Publication Date: 2025-11-13
Report Id: 2765164
Industry: Pharma & Healthcare
Report Page: 113
Chart: 116

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Prothrombin Complex Concentrate (PCC) Drug Definition
1.2 Global Prothrombin Complex Concentrate (PCC) Drug Market Size and Forecast
1.2.1 By Consumption Value, Global Prothrombin Complex Concentrate (PCC) Drug Market Size, 2020-2031
1.2.2 By Sales Quantity, Global Prothrombin Complex Concentrate (PCC) Drug Market Size, 2020-2031
1.2.3 Global Prothrombin Complex Concentrate (PCC) Drug Average Selling Price (ASP), 2020-2031
1.3 China Prothrombin Complex Concentrate (PCC) Drug Market Size and Forecast
1.3.1 By Consumption Value, China Prothrombin Complex Concentrate (PCC) Drug Market Size, 2020-2031
1.3.2 By Sales Quantity, China Prothrombin Complex Concentrate (PCC) Drug Market Size, 2020-2031
1.3.3 China Prothrombin Complex Concentrate (PCC) Drug Average Selling Price (ASP), 2020-2031
1.4 Share of China Prothrombin Complex Concentrate (PCC) Drug Market with Respect to the Global Market
1.4.1 By Consumption Value, China Prothrombin Complex Concentrate (PCC) Drug Market Share in Global, 2020-2031
1.4.2 By Sales Quantity, China Prothrombin Complex Concentrate (PCC) Drug Market Share in Global, 2020-2031
1.4.3 Prothrombin Complex Concentrate (PCC) Drug Market Size: China VS Global, 2020-2031
1.5 Prothrombin Complex Concentrate (PCC) Drug Market Dynamics
1.5.1 Prothrombin Complex Concentrate (PCC) Drug Market Drivers
1.5.2 Prothrombin Complex Concentrate (PCC) Drug Market Restraints
1.5.3 Prothrombin Complex Concentrate (PCC) Drug Industry Trends
1.5.4 Prothrombin Complex Concentrate (PCC) Drug Industry Policy

2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Prothrombin Complex Concentrate (PCC) Drug, Global Market Share by Company, 2020-2025
2.2 By Sales Quantity of Prothrombin Complex Concentrate (PCC) Drug, Global Market Share by Company, 2020-2025
2.3 Prothrombin Complex Concentrate (PCC) Drug Average Selling Price (ASP) by Company, 2020-2025
2.4 Global Prothrombin Complex Concentrate (PCC) Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Prothrombin Complex Concentrate (PCC) Drug Concentration Ratio
2.6 Global Prothrombin Complex Concentrate (PCC) Drug Mergers & Acquisitions, Expansion Plans
2.7 Global Prothrombin Complex Concentrate (PCC) Drug Manufacturers Product Type
2.8 Head Office and Prothrombin Complex Concentrate (PCC) Drug Production Site of Key Manufacturer
2.9 Prothrombin Complex Concentrate (PCC) Drug Capacity of Major Manufacturers and Future Plan

3 China Leading Manufacturers and Market Share
3.1 By Revenue of Prothrombin Complex Concentrate (PCC) Drug, China Market Share by Company, 2020-2025
3.2 By Sales Quantity of Prothrombin Complex Concentrate (PCC) Drug, China Market Share by Company, 2020-2025
3.3 China Prothrombin Complex Concentrate (PCC) Drug Prothrombin Complex Concentrate (PCC) Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions
4.1 Global Prothrombin Complex Concentrate (PCC) Drug Capacity, Output and Capacity Utilization, 2020-2031
4.2 Global Prothrombin Complex Concentrate (PCC) Drug Capacity by Region
4.3 Global Prothrombin Complex Concentrate (PCC) Drug Production & Forecast by Region, 2020 VS 2024 VS 2031
4.4 Global Prothrombin Complex Concentrate (PCC) Drug Production by Region, 2020-2031
4.5 Global Prothrombin Complex Concentrate (PCC) Drug Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Prothrombin Complex Concentrate (PCC) Drug Industry Chain
5.2 Prothrombin Complex Concentrate (PCC) Drug Upstream Analysis
5.2.1 Prothrombin Complex Concentrate (PCC) Drug Core Raw Materials
5.2.2 Main Manufacturers of Prothrombin Complex Concentrate (PCC) Drug Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Prothrombin Complex Concentrate (PCC) Drug Production Mode
5.6 Prothrombin Complex Concentrate (PCC) Drug Procurement Model
5.7 Prothrombin Complex Concentrate (PCC) Drug Industry Sales Model and Sales Channels
5.7.1 Prothrombin Complex Concentrate (PCC) Drug Sales Model
5.7.2 Prothrombin Complex Concentrate (PCC) Drug Typical Distributors

6 Sights by Type
6.1 Prothrombin Complex Concentrate (PCC) Drug Classification by Type
6.1.1 Beriplex
6.1.2 Profilnine
6.1.3 Octaplex
6.1.4 Prothromplex
6.1.5 Cofact
6.1.6 Other
6.2 by Type, Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value, 2020-2031
6.4 by Type, Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, 2020-2031
6.5 by Type, Global Prothrombin Complex Concentrate (PCC) Drug Average Selling Price (ASP), 2020-2031

7 Sights by Usage Type
7.1 Prothrombin Complex Concentrate (PCC) Drug Classification by Usage Type
7.1.1 Lyophilized Powder Form
7.1.2 Liquid Injection Form
7.2 by Usage Type, Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value & CAGR, 2020 VS 2024 VS 2031
7.3 by Usage Type, Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value, 2020-2031
7.4 by Usage Type, Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, 2020-2031
7.5 by Usage Type, Global Prothrombin Complex Concentrate (PCC) Drug Average Selling Price (ASP), 2020-2031

8 Sights by Manufacturing Process
8.1 Prothrombin Complex Concentrate (PCC) Drug Classification by Manufacturing Process
8.1.1 Plasma-Derived
8.1.2 Recombinant Bioengineered
8.2 by Manufacturing Process, Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value & CAGR, 2020 VS 2024 VS 2031
8.3 by Manufacturing Process, Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value, 2020-2031
8.4 by Manufacturing Process, Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, 2020-2031
8.5 by Manufacturing Process, Global Prothrombin Complex Concentrate (PCC) Drug Average Selling Price (ASP), 2020-2031

9 Sights by Application
9.1 Prothrombin Complex Concentrate (PCC) Drug Segment by Application
9.1.1 Hemophilia B
9.1.2 Acquired Coagulation Factor Deficiency
9.2 by Application, Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value & CAGR, 2020 VS 2024 VS 2031
9.3 by Application, Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value, 2020-2031
9.4 by Application, Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, 2020-2031
9.5 by Application, Global Prothrombin Complex Concentrate (PCC) Drug Price, 2020-2031

10 Sales Sights by Region
10.1 By Region, Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value, 2020 VS 2024 VS 2031
10.2 By Region, Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value, 2020-2031
10.3 By Region, Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, 2020-2031
10.4 North America
10.4.1 North America Prothrombin Complex Concentrate (PCC) Drug Market Size & Forecasts, 2020-2031
10.4.2 By Country, North America Prothrombin Complex Concentrate (PCC) Drug Market Size Market Share
10.5 Europe
10.5.1 Europe Prothrombin Complex Concentrate (PCC) Drug Market Size & Forecasts, 2020-2031
10.5.2 By Country, Europe Prothrombin Complex Concentrate (PCC) Drug Market Size Market Share
10.6 Asia Pacific
10.6.1 Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Market Size & Forecasts, 2020-2031
10.6.2 By Country/Region, Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Market Size Market Share
10.7 South America
10.7.1 South America Prothrombin Complex Concentrate (PCC) Drug Market Size & Forecasts, 2020-2031
10.7.2 By Country, South America Prothrombin Complex Concentrate (PCC) Drug Market Size Market Share
10.8 Middle East & Africa

11 Sales Sights by Country Level
11.1 By Country, Global Prothrombin Complex Concentrate (PCC) Drug Market Size & CAGR, 2020 VS 2024 VS 2031
11.2 By Country, Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value, 2020-2031
11.3 By Country, Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, 2020-2031
11.4 United States
11.4.1 United States Prothrombin Complex Concentrate (PCC) Drug Market Size, 2020-2031
11.4.2 by Type, United States Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share, 2024 VS 2031
11.4.3 by Application, United States Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share, 2024 VS 2031
11.5 Europe
11.5.1 Europe Prothrombin Complex Concentrate (PCC) Drug Market Size, 2020-2031
11.5.2 by Type, Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share, 2024 VS 2031
11.5.3 by Application, Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share, 2024 VS 2031
11.6 China
11.6.1 China Prothrombin Complex Concentrate (PCC) Drug Market Size, 2020-2031
11.6.2 by Type, China Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share, 2024 VS 2031
11.6.3 by Application, China Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share, 2024 VS 2031
11.7 Japan
11.7.1 Japan Prothrombin Complex Concentrate (PCC) Drug Market Size, 2020-2031
11.7.2 by Type, Japan Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share, 2024 VS 2031
11.7.3 by Application, Japan Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share, 2024 VS 2031
11.8 South Korea
11.8.1 South Korea Prothrombin Complex Concentrate (PCC) Drug Market Size, 2020-2031
11.8.2 by Type, South Korea Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share, 2024 VS 2031
11.8.3 by Application, South Korea Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share, 2024 VS 2031
11.9 Southeast Asia
11.9.1 Southeast Asia Prothrombin Complex Concentrate (PCC) Drug Market Size, 2020-2031
11.9.2 by Type, Southeast Asia Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share, 2024 VS 2031
11.9.3 by Application, Southeast Asia Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share, 2024 VS 2031
11.10 India
11.10.1 India Prothrombin Complex Concentrate (PCC) Drug Market Size, 2020-2031
11.10.2 by Type, India Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share, 2024 VS 2031
11.10.3 by Application, India Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share, 2024 VS 2031
11.11 Middle East & Africa
11.11.1 Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Market Size, 2020-2031
11.11.2 by Type, Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share, 2024 VS 2031
11.11.3 by Application, Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share, 2024 VS 2031

12 Manufacturers Profile
12.1 CSL Behring
12.1.1 CSL Behring Company Information, Head Office, Market Area, and Industry Position
12.1.2 CSL Behring Prothrombin Complex Concentrate (PCC) Drug Models, Specifications, and Application
12.1.3 CSL Behring Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.1.4 CSL Behring Company Profile and Main Business
12.1.5 CSL Behring Recent Developments
12.2 Grifols
12.2.1 Grifols Company Information, Head Office, Market Area, and Industry Position
12.2.2 Grifols Prothrombin Complex Concentrate (PCC) Drug Models, Specifications, and Application
12.2.3 Grifols Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.2.4 Grifols Company Profile and Main Business
12.2.5 Grifols Recent Developments
12.3 Octapharma
12.3.1 Octapharma Company Information, Head Office, Market Area, and Industry Position
12.3.2 Octapharma Prothrombin Complex Concentrate (PCC) Drug Models, Specifications, and Application
12.3.3 Octapharma Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.3.4 Octapharma Company Profile and Main Business
12.3.5 Octapharma Recent Developments
12.4 Prothya Biosolutions
12.4.1 Prothya Biosolutions Company Information, Head Office, Market Area, and Industry Position
12.4.2 Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Models, Specifications, and Application
12.4.3 Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.4.4 Prothya Biosolutions Company Profile and Main Business
12.4.5 Prothya Biosolutions Recent Developments
12.5 Takeda
12.5.1 Takeda Company Information, Head Office, Market Area, and Industry Position
12.5.2 Takeda Prothrombin Complex Concentrate (PCC) Drug Models, Specifications, and Application
12.5.3 Takeda Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.5.4 Takeda Company Profile and Main Business
12.5.5 Takeda Recent Developments
12.6 RAAS
12.6.1 RAAS Company Information, Head Office, Market Area, and Industry Position
12.6.2 RAAS Prothrombin Complex Concentrate (PCC) Drug Models, Specifications, and Application
12.6.3 RAAS Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.6.4 RAAS Company Profile and Main Business
12.6.5 RAAS Recent Developments
12.7 Hualan Bio
12.7.1 Hualan Bio Company Information, Head Office, Market Area, and Industry Position
12.7.2 Hualan Bio Prothrombin Complex Concentrate (PCC) Drug Models, Specifications, and Application
12.7.3 Hualan Bio Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.7.4 Hualan Bio Company Profile and Main Business
12.7.5 Hualan Bio Recent Developments
12.8 BOHUI
12.8.1 BOHUI Company Information, Head Office, Market Area, and Industry Position
12.8.2 BOHUI Prothrombin Complex Concentrate (PCC) Drug Models, Specifications, and Application
12.8.3 BOHUI Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.8.4 BOHUI Company Profile and Main Business
12.8.5 BOHUI Recent Developments
12.9 NUOYI BIO
12.9.1 NUOYI BIO Company Information, Head Office, Market Area, and Industry Position
12.9.2 NUOYI BIO Prothrombin Complex Concentrate (PCC) Drug Models, Specifications, and Application
12.9.3 NUOYI BIO Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.9.4 NUOYI BIO Company Profile and Main Business
12.9.5 NUOYI BIO Recent Developments
12.10 SINOPHARM
12.10.1 SINOPHARM Company Information, Head Office, Market Area, and Industry Position
12.10.2 SINOPHARM Prothrombin Complex Concentrate (PCC) Drug Models, Specifications, and Application
12.10.3 SINOPHARM Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.10.4 SINOPHARM Company Profile and Main Business
12.10.5 SINOPHARM Recent Developments
12.11 Guangdong Weilun
12.11.1 Guangdong Weilun Company Information, Head Office, Market Area, and Industry Position
12.11.2 Guangdong Weilun Prothrombin Complex Concentrate (PCC) Drug Models, Specifications, and Application
12.11.3 Guangdong Weilun Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.11.4 Guangdong Weilun Company Profile and Main Business
12.11.5 Guangdong Weilun Recent Developments
12.12 Weiguang Bio
12.12.1 Weiguang Bio Company Information, Head Office, Market Area, and Industry Position
12.12.2 Weiguang Bio Prothrombin Complex Concentrate (PCC) Drug Models, Specifications, and Application
12.12.3 Weiguang Bio Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.12.4 Weiguang Bio Company Profile and Main Business
12.12.5 Weiguang Bio Recent Developments
12.13 Kangbo Bio
12.13.1 Kangbo Bio Company Information, Head Office, Market Area, and Industry Position
12.13.2 Kangbo Bio Prothrombin Complex Concentrate (PCC) Drug Models, Specifications, and Application
12.13.3 Kangbo Bio Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.13.4 Kangbo Bio Company Profile and Main Business
12.13.5 Kangbo Bio Recent Developments
12.14 Huarun Boya
12.14.1 Huarun Boya Company Information, Head Office, Market Area, and Industry Position
12.14.2 Huarun Boya Prothrombin Complex Concentrate (PCC) Drug Models, Specifications, and Application
12.14.3 Huarun Boya Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.14.4 Huarun Boya Company Profile and Main Business
12.14.5 Huarun Boya Recent Developments
12.15 Taibang Biologic
12.15.1 Taibang Biologic Company Information, Head Office, Market Area, and Industry Position
12.15.2 Taibang Biologic Prothrombin Complex Concentrate (PCC) Drug Models, Specifications, and Application
12.15.3 Taibang Biologic Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.15.4 Taibang Biologic Company Profile and Main Business
12.15.5 Taibang Biologic Recent Developments

13 Conclusion

14 Appendix
14.1 Research Methodology
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Market Estimation Model
14.4 Disclaimer

According to YH Research, the global market for Prothrombin Complex Concentrate (PCC) Drug should grow from US$ 1408 million in 2024 to US$ 2724 million by 2031, with a CAGR of 9.7% for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Prothrombin Complex Concentrate (PCC) Drug

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

Prothrombin Complex Concentrate (PCC) drugs are plasma-derived, multi-factor coagulation products purified and viral-inactivated from human plasma. They primarily contain four vitamin K-dependent clotting factors—II, VII, IX, and X—and may also include natural anticoagulants such as protein C and protein S. PCC drugs are indicated for the treatment or prevention of bleeding caused by deficiencies in these factors, particularly in cases of warfarin overdose, severe liver dysfunction, or congenital coagulation disorders. Compared with traditional fresh frozen plasma, PCC offers faster onset of action, lower infusion volumes, and reduced infection risks, making it widely used in emergency anticoagulation reversal, surgical hemostasis, and critical bleeding management. With the growing number of patients on anticoagulant therapy and rising surgical and trauma care needs, PCC drugs are emerging as one of the fastest-growing segments in the global plasma-derived therapeutics market.In 2024, global Prothrombin Complex Concentrate (PCC) drugs production reached approximately 4.73 m units, with an average global market price of around US$ 280 perunit.The average gross profit margin of this product is 80%.

The expansion of the PCC drug market is driven by the growing clinical demand and the increasing reliance of healthcare systems on rapid hemostatic solutions. The rising prevalence of patients on anticoagulant therapy—especially those with atrial fibrillation, deep vein thrombosis, or valvular heart disease—has created significant demand for effective reversal agents. Furthermore, PCC’s rapid hemostatic effect in high-risk surgical procedures such as trauma, neurosurgery, and cardiothoracic operations has established it as a critical emergency medicine. New-generation four-factor PCCs are now recommended over three-factor formulations due to their superior efficacy in reversing warfarin effects. Meanwhile, technological advancements in viral inactivation, nanofiltration, and lyophilization have markedly enhanced product safety and stability, boosting market adoption worldwide.

Despite strong growth prospects, the PCC drug industry faces several structural challenges. The supply of human plasma remains constrained and highly regulated, with geographical concentration creating vulnerability to supply chain disruptions. Additionally, the risk of thrombosis associated with high-dose or repeated PCC administration imposes clinical caution. The long production cycle, complex cost structure, and high technical barriers also create significant entry challenges for new manufacturers. In some regions, the preference for lower-cost alternatives such as fresh frozen plasma or recombinant coagulation factors slows PCC adoption. Moreover, variations in national regulatory frameworks and blood product standards may further complicate global market expansion and compliance efforts.

The downstream demand for PCC drugs is becoming increasingly diversified. While traditionally used for warfarin reversal and management of severe bleeding, recent years have seen expanded indications, including bleeding associated with direct oral anticoagulants (DOACs), liver disease-related coagulopathy, perioperative anticoagulant reversal, and obstetric hemorrhage. National clinical guidelines have progressively positioned PCC as a first-line therapy for anticoagulation reversal, accelerating its adoption. In developed markets, PCC use has extended from intensive care units to emergency and general wards. In emerging economies, government healthcare programs and local plasma fractionation initiatives are driving broader market penetration. Looking ahead, standardized hospital inventory practices, emergency medicine training, and combined therapeutic protocols involving PCC and other hemostatic agents will further broaden its clinical scope.

The production of PCC drugs relies heavily on human plasma as the primary biological raw material. Its quality, supply stability, and regulatory compliance directly determine production capacity and product safety standards. Most plasma collection currently occurs in North America and Europe, where mature donor networks and traceable oversight systems are in place. With gradual policy liberalization, Asian countries such as China and India are emerging as new sources of plasma supply growth. In addition to plasma, the upstream chain involves critical components such as viral inactivation reagents, chromatographic media, and lyophilization equipment. While technological advances have improved yield and purity, the stringent ethical and regulatory constraints on plasma sourcing and international transport remain key bottlenecks in the global PCC supply chain.

This report studies and analyses global Prothrombin Complex Concentrate (PCC) Drug status and future trends, helps the client to determine the Prothrombin Complex Concentrate (PCC) Drug market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Prothrombin Complex Concentrate (PCC) Drug, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2024 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Prothrombin Complex Concentrate (PCC) Drug market size, history data 2020-2025, and forecast data 2026-2031, (US$ million) & (K Units)
(2) Global Prothrombin Complex Concentrate (PCC) Drug sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (K Units)
(3) China Prothrombin Complex Concentrate (PCC) Drug sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (K Units)
(4) Global Prothrombin Complex Concentrate (PCC) Drug key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Prothrombin Complex Concentrate (PCC) Drug key producing regions, capacity, production, and year over year growth
(6) Prothrombin Complex Concentrate (PCC) Drug industry chains, upstream, midstream and downstream
Market segment by players, this report covers
CSL Behring
Grifols
Octapharma
Prothya Biosolutions
Takeda
RAAS
Hualan Bio
BOHUI
NUOYI BIO
SINOPHARM
Guangdong Weilun
Weiguang Bio
Kangbo Bio
Huarun Boya
Taibang Biologic

Market segment by Type, covers
Beriplex
Profilnine
Octaplex
Prothromplex
Cofact
Other

Market segment by Usage Type, covers
Lyophilized Powder Form
Liquid Injection Form

Market segment by Manufacturing Process, covers
Plasma-Derived
Recombinant Bioengineered

Market segment by Application, can be divided into
Hemophilia B
Acquired Coagulation Factor Deficiency

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Prothrombin Complex Concentrate (PCC) Drug product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Prothrombin Complex Concentrate (PCC) Drug market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 3: China Prothrombin Complex Concentrate (PCC) Drug market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 4: Global key producing regions of Prothrombin Complex Concentrate (PCC) Drug, percent & CAGR, 2020-2031
Chapter 5: Prothrombin Complex Concentrate (PCC) Drug industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.